134 related articles for article (PubMed ID: 12396726)
21. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.
Feng F; Wang B; Sun X; Zhu Y; Tang H; Nan G; Wang L; Wu B; Huhe M; Liu S; Diao T; Hou R; Zhang Y; Zhang Z
Cancer Biol Ther; 2017 Jan; 18(1):51-62. PubMed ID: 28055291
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
van Bree C; Castro Kreder N; Loves WJ; Franken NA; Peters GJ; Haveman J
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):237-44. PubMed ID: 12182997
[TBL] [Abstract][Full Text] [Related]
23. Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.
Sei S; Mussio JK; Yang QE; Nagashima K; Parchment RE; Coffey MC; Shoemaker RH; Tomaszewski JE
Mol Cancer; 2009 Jul; 8():47. PubMed ID: 19594950
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):352-63. PubMed ID: 17258563
[TBL] [Abstract][Full Text] [Related]
25. Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Rogers P; Boxall FE; Allott CP; Stephens TC; Kelland LR
Eur J Cancer; 2002 Aug; 38(12):1653-60. PubMed ID: 12142057
[TBL] [Abstract][Full Text] [Related]
26. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis.
Gervasoni JE; Hindenburg AA; Vezeridis MP; Schulze S; Wanebo HJ; Mehta S
Anticancer Res; 2004; 24(5A):2617-26. PubMed ID: 15517865
[TBL] [Abstract][Full Text] [Related]
27. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
28. Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
Qiu F; Zhao X
J BUON; 2018; 23(1):117-123. PubMed ID: 29552770
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.
Shord SS; Patel SR
J Exp Clin Cancer Res; 2009 Jun; 28(1):76. PubMed ID: 19500405
[TBL] [Abstract][Full Text] [Related]
30. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
Jensen PB; Holm B; Sorensen M; Christensen IJ; Sehested M
Br J Cancer; 1997; 75(6):869-77. PubMed ID: 9062409
[TBL] [Abstract][Full Text] [Related]
31. Anti-proliferative activity and mechanism of action of titanocene dichloride.
Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
[TBL] [Abstract][Full Text] [Related]
32. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.
Kamat AM; Sethi G; Aggarwal BB
Mol Cancer Ther; 2007 Mar; 6(3):1022-30. PubMed ID: 17363495
[TBL] [Abstract][Full Text] [Related]
33. Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.
Vandana M; Sahoo SK
Eur J Pharm Biopharm; 2015 Aug; 94():83-93. PubMed ID: 25968494
[TBL] [Abstract][Full Text] [Related]
34. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
Bunn PA
Semin Oncol; 1999 Feb; 26(1 Suppl 4):25-30. PubMed ID: 10201518
[TBL] [Abstract][Full Text] [Related]
35. Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.
Natsume T; Watanabe J; Horiuchi T; Kobayashi M
Anticancer Res; 2006; 26(2A):1145-51. PubMed ID: 16619516
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line.
Kanzawa F; Akiyama Y; Saijo N; Nishio K
Lung Cancer; 2003 Jun; 40(3):325-32. PubMed ID: 12781432
[TBL] [Abstract][Full Text] [Related]
37.
Iijima Y; Bandow K; Sano M; Hino S; Kaneko T; Horie N; Sakagami H
Anticancer Res; 2019 Dec; 39(12):6673-6684. PubMed ID: 31810932
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer--response rates to chemotherapeutic agents studied in vitro.
Kornblith P; Wells A; Gabrin MJ; Piwowar J; George LD; Ochs RL; Burholt D
Anticancer Res; 2003; 23(4):3405-11. PubMed ID: 12926081
[TBL] [Abstract][Full Text] [Related]
39. L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.
Nurcahyanti AD; Wink M
Anticancer Agents Med Chem; 2017; 17(2):206-211. PubMed ID: 26902604
[TBL] [Abstract][Full Text] [Related]
40. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
